Why Dr. Reddy's Laboratories Limited’s (RDY) Stock Is Up 5.18%
As of Thursday, September 17, Dr. Reddy's Laboratories Limited’s RDY share price has surged by 5.18%, which has investors questioning if this is right time to sell.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Pharmaceuticals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Jenna Brashear
Jenna Brashear
| Share Statistics | RDY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $12,456.9 | $421.0 | 81% |
|
| Shares Out (Mil) | 8.7 | 46.5 | 19% |
|
| Institutional Ownership | 68.7% | 82.0% | 42% |
|
| Float (Mil) | 600.1 | 48.3 | 87% |
|
| Beta | 0.25 | 0.68 | 14% |
|
| Avg Daily Volume (000s) | 2,378 | 348 | 83% |
|
| Price Change (52-week) |
7.3% | 52.0% | 57% |
|
| Growth | RDY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 6.7% | 6.6% | 45% |
|
| Net Income (5yr) | 14.2% | (1.6%) | 62% |
|
| EPS (5yr) | 14.1% | 15.1% | 55 |
|
| Dividends (5yr) | 4.5% | 0.0% | 56% |
|
| Cash Flow (5yr) | (43.0%) | (15.1%) | 10% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RDY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,440 | $289 | 68% |
|
| Net Income (TTM) (Mil) | $292 | ($11) | 71% |
|
| EPS (TTM) | $0.351 | ($0.600) | 50% |
|
| Operating Cash Flow (TTM) (Mil) | $322 | ($7) | 65% |
|
| Net Cash Flow (TTM) (Mil) | $39 | $1 | 68% |
|
| Long-Term Debt (Q1) (Mil) | $122 | $4 | 46% |
|
| Enterprise Value (Q1) (Mil) | $11,313 | $331 | 76% |
|
| Valuation | RDY | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.10 | 2.27 | 70% |
|
| P/E | 42.8 | 24.1 | 84% |
|
| Dividend Yield | 0.6% | 0.0% | 63% |
|
| PEG (5yr hist) | 3.0 | 1.2 | 80% |
|
| Ratios | RDY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 49.5% | 69.4% | 61% |
|
| Net Margin | 8.5% | 3.9% | 58% |
|
| ROA | 4.8% | (23.8%) | 70% |
|
| ROE | 7.2% | (24.7%) | 48% |
|
| Liabilities to Assets | 32.2% | 32.0% | 23% |
|
| F-Score | 6 | 3 | 67% |
|
Dr. Reddy's Laboratories Limited did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors